Massive biobank aims to crack the code of rare diseases
NCT ID NCT04703179
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
Mayo Clinic is creating a biobank of samples from 5,000 people with rare or undiagnosed diseases, along with their family members. Researchers will analyze DNA, RNA, and other samples to find markers and causes of these conditions. The goal is to build a library of information that could lead to better diagnosis and treatment in the future.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this biobank could help researchers discover new disease markers and causes, pointing toward better diagnosis and treatments for rare and undiagnosed conditions.
- What could go wrong
- This is an observational study, not a treatment trial. It may take years to yield useful results, and not all participants will receive a diagnosis or direct benefit.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RARE DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic in Arizona
Scottsdale, Arizona, 85259, United States
-
Mayo Clinic in Florida
Jacksonville, Florida, 32224, United States
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- One-shot gene editor aims to correct a brain disorder at its source
- Hackathon for the undiagnosed: mayo clinic launches repository to crack rare disease cases
- Biobank aims to unlock genetic secrets of rare diseases
- AI could shorten the long road to a rare disease diagnosis
- New hope for kids with MVID: drug aims to cut diarrhea and IV needs
- Scientists launch study to map rare baker gordon syndrome from childhood to adulthood